Skip to main content

Cardinal Health, Inc. (CAH)

NYSE: CAH · IEX Real-Time Price · USD
48.10 0.40 (0.84%)
Dec 7, 2021 4:00 PM EST - Market closed
Market Cap13.55B
Revenue (ttm)167.37B
Net Income (ttm)1.14B
Shares Out281.79M
EPS (ttm)3.87
PE Ratio12.42
Forward PE8.42
Dividend$1.95 (4.06%)
Ex-Dividend DateDec 31, 2021
Previous Close47.70
Day's Range47.54 - 48.40
52-Week Range45.85 - 62.96
Price Target57.31 (+19.1%)
Earnings DateNov 9, 2021

About CAH

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products...

IndustryHealth Care Providers & Services
CEOMichael Kaufmann
Stock ExchangeNYSE
Ticker SymbolCAH
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 15 analysts, the average rating for CAH stock is "Hold." The 12-month stock price forecast is 57.31, which is an increase of 19.15% from the latest price.

Price Target
(19.15% upside)
Analyst Consensus: Hold


Here's Why You Should Retain Cardinal Health (CAH) Stock Now

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio. However, contraction in gross margin is a woe.

1 day ago - Zacks Investment Research

3 Incredible Value Stocks to Buy Before 2021 Is Over

Great companies trading at cheap prices? Yes, please.

Other symbols:DISZNGA
3 days ago - The Motley Fool

Clarity and Cardinal Health enter into Agreement for Targeted Copper Theranostics

SYDNEY, Dec. 2, 2021 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in onco...

5 days ago - PRNewsWire

5 Dividend Aristocrat Bargains Near 52-week Lows

As people kick off Black Friday shopping across the U.S., five dividend aristocrat stocks with high guru ownership that are trading near 52-week lows are Cardinal Health Inc. ( CAH , Financial), AT&T In...

Other symbols:IBMLEGMDTT
1 week ago - GuruFocus

3 Promising Stocks From the Buoyant Dental Supplies Industry

Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain f...

Other symbols:MCKWST
2 weeks ago - Zacks Investment Research

Cardinal Health's (CAH) Arm Unveils Supply Automation Solution

Cardinal Health's (CAH) business introduces new offering for clinical labs that can enable them to focus on patient care.

2 weeks ago - Zacks Investment Research

Cardinal Health's WaveMark™ launches supply automation solution for clinical labs

DUBLIN, Ohio, Nov. 18, 2021 /PRNewswire/ -- Cardinal Health today announced its business, WaveMark™ Supply Management and Workflow Solutions, will now be available for implementation in clinical labs ac...

2 weeks ago - PRNewsWire

McKesson, Cardinal Health, AmerisourceBergen Face $95B Opioid Trial In Washington: Reuters

A Washington state trial against McKesson Corporation (NYSE: MCK), Cardinal Health Inc (NYSE: CAH), and AmerisourceBergen Corp (NYSE: ABC) for the U.S. opioid epidemic is slated to kick off today, Reute...

Other symbols:ABCMCK
3 weeks ago - Benzinga

Cardinal Health (CAH) Q1 Earnings Lag, Revenues Top Estimates

Although Cardinal Health (CAH) witnessed gross margin contraction in its fiscal first-quarter results, rise in revenues in both its segments is encouraging.

4 weeks ago - Zacks Investment Research

Cardinal Health (CAH) Misses Q1 Earnings Estimates

Cardinal (CAH) delivered earnings and revenue surprises of -2.27% and 5.29%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

4 weeks ago - Zacks Investment Research

Cardinal Health Post Mixed Q1 Earnings; Reaffirms FY22 Adjusted EPS Outlook

Cardinal Health (NYSE: CAH) reported Q1 FY22 adjusted EPS of $1.29, down from $1.51 a year ago, missing the Street estimate of $1.33. Q1 sales increased 13% Y/Y to $44 billion, beating the consensus est...

4 weeks ago - Benzinga

Cardinal Health Reports First Quarter Fiscal 2022 Results

DUBLIN, Ohio, Nov. 9, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2022 revenues of $44.0 billion, an increase of 13% from the first quarter of last year. Fi...

4 weeks ago - PRNewsWire

Cardinal Health Board of Directors Approves Quarterly Dividend

DUBLIN, Ohio, Nov. 4, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on Jan...

1 month ago - PRNewsWire

Biosimilars 101: A Q&A with Sonia T. Oskouei, Cardinal Health Vice President of Biosimilars

DUBLIN, Ohio, Nov. 4, 2021 /PRNewswire/ -- Biologics are the fastest growing class of drugs in the U.S.; they bring innovative, life-changing treatments to patients with cancer and chronic diseases. Due...

1 month ago - PRNewsWire

Cardinal Health (CAH) to Post Q1 Earnings: What's in Store?

Cardinal Health's (CAH) fiscal first-quarter results are likely to reflect solid performance in the Pharmaceutical segment.

1 month ago - Zacks Investment Research

Exo Adds Key Industry Leaders to Its Board and Executive Leadership Team

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- #POCUS--Exo (pronounced “echo”) is expanding its board of directors and adding key industry leaders to take POCUS ultrasound imaging everywhere.

1 month ago - Business Wire

Analysts Estimate Cardinal Health (CAH) to Report a Decline in Earnings: What to Look Out for

Cardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Cardinal Health Awarded FDA Funding to Assess Real World Evidence Results Against Clinical Trials

DUBLIN, Ohio, Oct. 28, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today it has been awarded a $750,000 contract by the U.S. Food and Drug Administration (FDA) to implement an 18-month re...

1 month ago - PRNewsWire

Cardinal Health expands solutions to mitigate missed cancer screenings

DUBLIN, Ohio, Oct. 25, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today its cancer screening offerings from FUJIFILM Healthcare Americas Corporation and Polymedco that can be done either...

1 month ago - PRNewsWire

Cardinal Health's (CAH) Unit Ties Up to Boost Diabetes Care

Cardinal Health's (CAH) company, OptiFreight Logistics', recent collaboration with Journey Biosciences to help patients with respect to long-term diabetes care.

1 month ago - Zacks Investment Research

Got $10,000? These 3 Dividend Stocks Are on Sale

Make the most of your money with these income-producing investments.

Other symbols:TGTWU
1 month ago - The Motley Fool

Journey Biosciences and Cardinal Health OptiFreight® Logistics Collaborate to Improve Long-Term Diabetes Care

LEBANON, N.H., Oct. 14, 2021 /PRNewswire/ -- Journey Biosciences, Inc., a biotechnology company with an innovative proactive diagnostic screening technology for high risk kidney complications, including...

1 month ago - PRNewsWire

3 Top Dividend Aristocrat Stocks for $55 or Less

At least one of them has been known to bring a smile to faces.

Other symbols:ENBKO
1 month ago - The Motley Fool

Business solutions for the next public health emergency

DUBLIN, Ohio, Oct. 12, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today its Strategic Stock Solution now serves nearly 40 hospitals and health systems nationwide, just one year after its...

1 month ago - PRNewsWire

New Cardinal Health survey explores how rheumatologists are managing current industry dynamics including changing rei...

DUBLIN, Ohio, Oct. 6, 2021 /PRNewswire/ -- While demand for rheumatology care continues to grow, rheumatologists are feeling pressured by reimbursement changes, administrative duties and workforce short...

2 months ago - PRNewsWire